Masters 2 in Health Economics
Thomas Rapp, Masters Director
The health market is in full expansion in the Middle East. This strong expansion is accompanied by a number of questions, such as, for instance: what is the right level of reimbursement for a medical act? What economic criteria must be applied to determine medicine prices? Should one invest in the development of a new molecule? Is it profitable to introduce a tele-medicine mechanism to monitor a chronic disease? What is the efficiency of prevention campaigns for certain ‘risk’ behaviors? Is health the only factor to determine the path to follow in treating diseases? How can one efficiently organize the coverage of diseases?
Consequently, market actors (Health authorities, industrials, researchers, hospitals, practitioners) face a number of major challenges relative, on the one hand, to the production and organization of care; and on the other hand, to the evaluation of the efficiency of innovations and public policies.
In order to tackle these challenges, these actors can build on various sources of information. The creation of various administrative databases by public and private organizations engaged in the care reimbursement or even the launch of studies or cohorts, constitute important sources of information for public and private decision makers. The analysis of this Big Data implies mastering advanced theoretical and empirical tools.
The first year of the program (directed by Dr. Sébastien Cochinard, Paris-Descartes) focuses on fundamental subjects to equip students with the basics of economic analysis. Professors of year one will address, in particular, the comprehension of social protection systems, learning of linear econometrics models and the STATA® statistics software.
During the second year, (directed by Dr. Thomas Rapp, Paris-Descartes) students specialize in health economics. Teachings of year two focus on three main topics: the economic evaluation of health technology (the Markov model and its implementation on cost effective analysis), the economic evaluation of health policies (econometrics of panel data, propensity scores, collective decisions and social choices), and the study of behaviors on the health and insurance markets (behavioral economy, game theory, insurance demand, etc.). Students will receive training on best international practices of analysis methods through a pedagogic approach that is pragmatic and oriented towards mastering technical tools and the practical implementation based on scientific literature. The program favors a methodology centered around students’ capacity to formulate accurate working hypotheses on sound scientific grounds, to elaborate methods to evaluate these hypotheses, and to perform a critical analysis of the results that was obtained. This scientific step is inherent to the established tradition of Paris-Descartes, whose academic positioning in the field of health is a reference on the international level.
The Masters 2 in health economics allows students to master the needed empirical and theoretical tools for the economic evaluation of health technologies and policies. It provides an overview of the health economics combined with an in-depth view of the various specificities of the field: cost effectiveness analysis, budget impact study, econometrics, game theory, etc. It is quite oriented towards the empirical evaluation.
The tools taught in the Masters are largely used internationally. Emphasis is given to economic calculation models and techniques corresponding to international standards defined for the economic evaluation of health by learned institutions and health organizations. Furthermore, applications based on international practical cases are provided allowing students to master the technique of the tools being taught.
The proposed program also initiates students to academic research, through their participation in research seminars and developing a research dissertation. It shall therefore be based on the research program in health economics established by PSUAD. Many IT sessions will help students master work on databases.
Attendance is mandatory and assessment of students is done through exams at the end of each semester. Classes are delivered in the afternoon, after 3.30 p.m. allowing students with careers to pursue their studies.
Classes are delivered by professional experts and university professors with a solid international experience in the field of health economic evaluations. The faculty is constituted based on the following two criteria: strong research activity and publications in international magazines with reading committees and/or a vast experience in economic evaluation within health authorities and institutions.
The Masters 2 in health economics offers students a training on evaluation methods used in the health industry, by health organizations, and academic research internationally. It offers important career potentials in both the public and private sectors. It guarantees graduates are equipped with the set of tools needed to fill directors positions in: departments with access to the pharmaceutical laboratories, economic evaluation units giving an opinion on efficiency in health authorities, strategy consultants. It also allows future entrepreneurs to master the methods used to process Big Data in the health sector. Finally, it allows students interested in humanitarian work to master the needed tools to evaluate the efficiency of interventions in the health sector in developing countries. Those who choose to be more research oriented can also pursue a PhD in health economics.
This academic program targets the graduates of Middle East universities as well as health professionals, employees in the health industry, members of public administrations, or even researchers looking to expand their perspective and experience internationally. This program is open to students from an economic or management background, but also to graduates in medical sciences: medicine, pharmacy, epidemiology, etc.